Inhibitors of JMJD2C as Anticancer Agents
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Feb 16, 2017
app pub date -
Apr 21, 2015
filing date -
Apr 28, 2014
priority date (Note) -
Published
status (Latency Note)
Importance
Calculated Rating
|
US Family Size
|
Non-US Coverage
|
Abstract
The present disclosure provides compounds, pharmaceutical compositions and related methods for the treatment of cancer, e.g., castration-resistant prostate cancer (CRPC). Specifically, the present disclosure provides a series of 8-hydroxyquinoline derivatives which show cytotoxic effects on androgen-independent prostate cancer cells.
First Claim
Other Claims data not available
Family
+
−
| Country | kind | publication No. | Filing Date |
|---|---|---|---|
| WO | A1 | WO2015167874 | Apr 21, 2015 |
| EP | A1 | EP3137079 | Apr 21, 2015 |
International Classification(s)
- 2015 Application Filing Year
- C07D Class
- 5466 Applications Filed
- 4606 Patents Issued To-Date
- 84.27 % Issued To-Date
Cited Art Landscape
Patent Citation Ranking
- 0 Citation Count
- C07D Class
- 0 % this patent is cited more than
- 8 Age